nodes	percent_of_prediction	percent_of_DWPC	metapath
Altretamine—Ovarian cancer—Docetaxel—head and neck cancer	0.0982	0.0982	CcSEcCtD
Altretamine—Myelosuppression—Vinblastine—head and neck cancer	0.0767	0.0767	CcSEcCtD
Altretamine—Myelosuppression—Hydroxyurea—head and neck cancer	0.0699	0.0699	CcSEcCtD
Altretamine—Myelosuppression—Fluorouracil—head and neck cancer	0.0503	0.0503	CcSEcCtD
Altretamine—Neurotoxicity—Docetaxel—head and neck cancer	0.0439	0.0439	CcSEcCtD
Altretamine—Myelosuppression—Docetaxel—head and neck cancer	0.0363	0.0363	CcSEcCtD
Altretamine—Neoplasm—Vinblastine—head and neck cancer	0.0325	0.0325	CcSEcCtD
Altretamine—Neoplasm—Hydroxyurea—head and neck cancer	0.0296	0.0296	CcSEcCtD
Altretamine—Pancytopenia—Vinblastine—head and neck cancer	0.0214	0.0214	CcSEcCtD
Altretamine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.0197	0.0197	CcSEcCtD
Altretamine—Pancytopenia—Hydroxyurea—head and neck cancer	0.0195	0.0195	CcSEcCtD
Altretamine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.018	0.018	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.017	0.017	CcSEcCtD
Altretamine—Ataxia—Fluorouracil—head and neck cancer	0.0161	0.0161	CcSEcCtD
Altretamine—Neoplasm—Docetaxel—head and neck cancer	0.0154	0.0154	CcSEcCtD
Altretamine—Anaemia—Vinblastine—head and neck cancer	0.0145	0.0145	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.0142	0.0142	CcSEcCtD
Altretamine—Vertigo—Vinblastine—head and neck cancer	0.0141	0.0141	CcSEcCtD
Altretamine—Leukopenia—Vinblastine—head and neck cancer	0.0141	0.0141	CcSEcCtD
Altretamine—Pancytopenia—Fluorouracil—head and neck cancer	0.0141	0.0141	CcSEcCtD
Altretamine—Convulsion—Vinblastine—head and neck cancer	0.0136	0.0136	CcSEcCtD
Altretamine—Anaemia—Hydroxyurea—head and neck cancer	0.0132	0.0132	CcSEcCtD
Altretamine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.0129	0.0129	CcSEcCtD
Altretamine—Leukopenia—Hydroxyurea—head and neck cancer	0.0128	0.0128	CcSEcCtD
Altretamine—Thrombocytopenia—Vinblastine—head and neck cancer	0.0126	0.0126	CcSEcCtD
Altretamine—Convulsion—Hydroxyurea—head and neck cancer	0.0124	0.0124	CcSEcCtD
Altretamine—Anorexia—Vinblastine—head and neck cancer	0.0122	0.0122	CcSEcCtD
Altretamine—Ataxia—Docetaxel—head and neck cancer	0.0116	0.0116	CcSEcCtD
Altretamine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.0115	0.0115	CcSEcCtD
Altretamine—Anorexia—Hydroxyurea—head and neck cancer	0.0112	0.0112	CcSEcCtD
Altretamine—Decreased appetite—Vinblastine—head and neck cancer	0.0112	0.0112	CcSEcCtD
Altretamine—Decreased appetite—Hydroxyurea—head and neck cancer	0.0102	0.0102	CcSEcCtD
Altretamine—Pancytopenia—Docetaxel—head and neck cancer	0.0101	0.0101	CcSEcCtD
Altretamine—Fatigue—Hydroxyurea—head and neck cancer	0.0101	0.0101	CcSEcCtD
Altretamine—Anaemia—Fluorouracil—head and neck cancer	0.00954	0.00954	CcSEcCtD
Altretamine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00934	0.00934	CcSEcCtD
Altretamine—Leukopenia—Fluorouracil—head and neck cancer	0.00923	0.00923	CcSEcCtD
Altretamine—Asthenia—Vinblastine—head and neck cancer	0.0092	0.0092	CcSEcCtD
Altretamine—Convulsion—Fluorouracil—head and neck cancer	0.00894	0.00894	CcSEcCtD
Altretamine—Dizziness—Vinblastine—head and neck cancer	0.00848	0.00848	CcSEcCtD
Altretamine—Asthenia—Hydroxyurea—head and neck cancer	0.00839	0.00839	CcSEcCtD
Altretamine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00824	0.00824	CcSEcCtD
Altretamine—Vomiting—Vinblastine—head and neck cancer	0.00816	0.00816	CcSEcCtD
Altretamine—Anorexia—Fluorouracil—head and neck cancer	0.00803	0.00803	CcSEcCtD
Altretamine—Dizziness—Hydroxyurea—head and neck cancer	0.00774	0.00774	CcSEcCtD
Altretamine—Nausea—Vinblastine—head and neck cancer	0.00762	0.00762	CcSEcCtD
Altretamine—Vomiting—Hydroxyurea—head and neck cancer	0.00744	0.00744	CcSEcCtD
Altretamine—Decreased appetite—Fluorouracil—head and neck cancer	0.00732	0.00732	CcSEcCtD
Altretamine—Nausea—Hydroxyurea—head and neck cancer	0.00695	0.00695	CcSEcCtD
Altretamine—Anaemia—Docetaxel—head and neck cancer	0.00688	0.00688	CcSEcCtD
Altretamine—Leukopenia—Docetaxel—head and neck cancer	0.00667	0.00667	CcSEcCtD
Altretamine—Convulsion—Docetaxel—head and neck cancer	0.00645	0.00645	CcSEcCtD
Altretamine—Thrombocytopenia—Docetaxel—head and neck cancer	0.00595	0.00595	CcSEcCtD
Altretamine—Anorexia—Docetaxel—head and neck cancer	0.00579	0.00579	CcSEcCtD
Altretamine—Dizziness—Fluorouracil—head and neck cancer	0.00557	0.00557	CcSEcCtD
Altretamine—Vomiting—Fluorouracil—head and neck cancer	0.00535	0.00535	CcSEcCtD
Altretamine—Decreased appetite—Docetaxel—head and neck cancer	0.00528	0.00528	CcSEcCtD
Altretamine—Fatigue—Docetaxel—head and neck cancer	0.00524	0.00524	CcSEcCtD
Altretamine—Nausea—Fluorouracil—head and neck cancer	0.005	0.005	CcSEcCtD
Altretamine—Asthenia—Docetaxel—head and neck cancer	0.00436	0.00436	CcSEcCtD
Altretamine—Dizziness—Docetaxel—head and neck cancer	0.00402	0.00402	CcSEcCtD
Altretamine—Vomiting—Docetaxel—head and neck cancer	0.00386	0.00386	CcSEcCtD
Altretamine—Nausea—Docetaxel—head and neck cancer	0.00361	0.00361	CcSEcCtD
